When Bibo in Xin anjiang meets the pride of Mount Huangshan Pine, and when the Anhui style ancient charm collision team is enthusiastic, the 2025 group building activity of Jiangsu Weihe Biotechnology
2025-04-22
Any genetic polymorphism that can be detected in the blood can be referred to as blood type, but blood type is usually limited to the polymorphism of blood cell surface antigens, including red blood c
2025-04-02
The 22nd China International Laboratory Medicine and Blood Transfusion Instrument Reagent Expo (CACLP) and the 5th China International IVD Upstream Raw Materials and Supply Chain Expo (CISCE) will be
2025-03-19
Pregnancy is the happiest moment for every family, but some potential health risks may cast a shadow over this happiness.
2025-03-08
At a time when the global biopharmaceutical industry is undergoing changes, the industry is also looking forward to the biopharmaceutical industry moving towards a more fair, healthy, and stable marke
2025-02-17
In the context of industry restructuring, market downturn, and unstable business factors, Weihe Biotechnology still achieved a 50% increase in revenue and doubled profits for the whole year of 2024. W
2025-01-29
The Weihe booth showcased our innovative achievements in the field of transplantation and blood transfusion through a series of products such as human leukocyte (HLA), platelet (HPA), and red blood ce
2024-07-16
The National Platelet Management and Application Conference, jointly organized by the Human Antigen Professional Committee of the Chinese Blood Transfusion Association, the Clinical Blood Transfusion
2024-04-22
Through in-depth online communication and preparation, Weihe Biotechnology has directly visited Iranian customers for the first time. Iran is a traditional country with a high demand for transplant di
2024-02-08
On the morning of October 26th, leaders from the Administrative Approval Department of Jiangsu Provincial Drug Administration and Taizhou Inspection Sub bureau, along with experts from the Provincial
2023-10-27